US 11155533
Crystalline forms and compositions of CFTR modulators
granted A61KA61K9/10A61K9/2013
Quick answer
US patent 11155533 (Crystalline forms and compositions of CFTR modulators) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Oct 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K9/10, A61K9/2013, A61K9/2054, A61P